Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)
This paper summarises the position of ESGO and EFC on cervical screening based on
existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as …
existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as …
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
ETH Fontham, AMD Wolf, TR Church… - CA: a cancer journal …, 2020 - Wiley Online Library
Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …
initiate cervical cancer screening at age 25 years and undergo primary human …
Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve
H Masson - Women's Health, 2021 - journals.sagepub.com
Background: The Coronavirus disease 2019 (COVID-19) pandemic has led to an
unprecedented upheaval within global healthcare systems and resulted in the temporary …
unprecedented upheaval within global healthcare systems and resulted in the temporary …
Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country
Objective To report a modelling study using local health care costs and epidemiological
inputs from a population-based program to access the cost-effectiveness of adopting hrHPV …
inputs from a population-based program to access the cost-effectiveness of adopting hrHPV …
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non …
AG Marson, G Burnside, R Appleton… - Health Technology …, 2021 - research.bangor.ac.uk
The aims of the SANAD II trial were to assess the longer-term clinical effectiveness and
costeffectiveness of levetiracetam and zonisamide compared with lamotrigine in focal …
costeffectiveness of levetiracetam and zonisamide compared with lamotrigine in focal …
Cervical cancer screening in Jordan; a review of the past and an outlook to the future–facts and figures
Results Among 655 women who responded to the questionnaire, 340 (51.9%) reported
having no idea about the smear, 350 (53.4%) had completed higher education, 84 (12.84%) …
having no idea about the smear, 350 (53.4%) had completed higher education, 84 (12.84%) …
Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a …
Background Regarding primary and secondary cervical cancer prevention, the World Health
Organization proposed the cervical cancer elimination strategy that requires countries to …
Organization proposed the cervical cancer elimination strategy that requires countries to …
Te Ara Waiora–implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: a protocol for a non-inferiority trial
M Gibson-Helm, T Slater, EJ MacDonald, K Stevenson… - Plos one, 2023 - journals.plos.org
Background Cervical cancer is caused by high-risk types of human papillomavirus (HPV).
Testing for high-risk HPV is a more sensitive screening method than cervical cytology for …
Testing for high-risk HPV is a more sensitive screening method than cervical cytology for …
Patterns of anxiety and distress over 12 months following participation in HPV primary screening
LAV Marlow, E McBride, D Ridout, AS Forster… - Sexually transmitted …, 2022 - sti.bmj.com
Objectives Many countries are now using primary human papillomavirus (HPV) testing for
cervical screening, testing for high-risk HPV and using cytology as triage. An HPV-positive …
cervical screening, testing for high-risk HPV and using cytology as triage. An HPV-positive …
Treatment methods for cervical intraepithelial neoplasia in England: A cost‐effectiveness analysis
Objective To compare the cost‐effectiveness of different treatments for cervical intraepithelial
neoplasia (CIN). Design A cost‐effectiveness analysis based on data available in the …
neoplasia (CIN). Design A cost‐effectiveness analysis based on data available in the …